Status:
RECRUITING
Retrospective Analyses of TrakStar Database
Lead Sponsor:
Neuronetics
Conditions:
Depression
Obsessive-Compulsive Disorder
Eligibility:
All Genders
5-120 years
Brief Summary
In this study, real-world data will be used to better understand the effects patient characteristics, symptoms and TMS protocol parameters have on clinical outcomes with NeuroStar TMS.
Eligibility Criteria
Inclusion
- Male or female reported in database and not an invalid entry
- Age reported and not an invalid entry
- Treatment date of November 01, 2008 or later.
Exclusion
- • Incomplete information on treatment parameters
Key Trial Info
Start Date :
February 25 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2035
Estimated Enrollment :
156000 Patients enrolled
Trial Details
Trial ID
NCT06917339
Start Date
February 25 2025
End Date
December 1 2035
Last Update
April 8 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Neuronetics
Malvern, Pennsylvania, United States, 19355